Hydration Pharmaceuticals Reinstated to Quotation
Key points
- Trading suspension lifted following lodgement of Annual Report
- Shares to resume trading on Monday, 4 May 2026
- Reinstatement follows previously announced suspension
Full summary
The Hydration Pharmaceuticals Company Ltd (ASX: HPC) has announced that the suspension of trading in its securities will be lifted from the commencement of trading on Monday, 4 May 2026. This follows the lodgement of the company's Annual Report. The suspension was previously announced by the ASX. With the reinstatement, HPC's shares will resume trading on the Australian Securities Exchange from the start of the trading day on 4 May 2026.
Summary generated by a large language model. Please interpret with care.